Alibaba Health Information Technology (00241) said its loss attributable to owners of the parent for the year ended 31 March 2018 narrowed to Rmb107 million from Rmb208 million for the previous financial year.
Basic and diluted loss per share was Rmb1.16 cents.
Revenue amounted to Rmb2,443 million, an increase of 414% from a year earlier. Gross profit soared 248.7% year-on-year to Rmb653 million. Such strong growth in revenue and gross profit was mainly attributable to the rapid growth in revenue from self-operated healthcare product sales and e-commerce platform services during the year.
No final dividend will be distributed.
全新etnet健康網購,送你【健骨維他命D3(1000IU)】乙樽(價值$108)► 立即行動!